Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0CF2Q
|
||||
Former ID |
DAP000570
|
||||
Drug Name |
Levamisole
|
||||
Synonyms |
Ketrax; LEVOMYSOL; Lepuron; Levamisol; Levamisolum; Levotetramisole; Tetramisol; Wormicid; Levamisole Base;Nilverm base; P00039; Vermisol 150; Dl-Tetramisol; Dl-Tetramisole; Ergamisol (TN); Ketrax (TN); L-Tetramisole; Levamisol [INN-Spanish]; Levamisole (INN); Levamisole [INN:BAN]; Levamisolum [INN-Latin]; TCMDC-125847; L(-)-Levamisole; L-2,3,5,6-Tetrahyro-6-phenylimidazo(2,1-b)thiazole; (-)-Tetramisole; (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole; (S)-(-)-Levamisole
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anticancer Agents
|
||||
Company |
Janssen Pharmaceutica
|
||||
Structure |
Download2D MOL |
||||
Formula |
C11H12N2S
|
||||
InChI |
InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1
|
||||
InChIKey |
HLFSDGLLUJUHTE-SNVBAGLBSA-N
|
||||
CAS Number |
CAS 14769-73-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9282, 602395, 7979761, 8169434, 10322011, 11335842, 11361081, 11364503, 11367065, 11369627, 11371883, 11374574, 11377789, 11405871, 11462053, 11466210, 11467330, 11484645, 11485760, 11488681, 11490777, 11492892, 11495423, 14748767, 15171780, 34669469, 46509052, 47440260, 47589003, 47736487, 47736488, 48035125, 48416165, 49761633, 49831041, 49981671, 50111118, 53790505, 56313649, 56313755, 57310333, 76000434, 85789251, 85860304, 90341409, 92309280, 92717075, 93166530, 96024804, 103523408
|
||||
SuperDrug ATC ID |
P02CE01
|
||||
SuperDrug CAS ID |
cas=014769734
|
||||
Target and Pathway | |||||
Target(s) | Alkaline phosphatase, tissue-nonspecific | Target Info | Inhibitor | [536820] | |
KEGG Pathway | Folate biosynthesis | ||||
Metabolic pathways | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PathWhiz Pathway | Vitamin B6 Metabolism | ||||
References | |||||
Ref 536772 | New drugs in development for the treatment of endometriosis. Expert Opin Investig Drugs. 2008 Aug;17(8):1187-202. | ||||
Ref 542225 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7210). | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.